These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19885616)

  • 1. Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method.
    Ji NY; Park MY; Kang YH; Lee CI; Kim DG; Yeom YI; Jang YJ; Myung PK; Kim JW; Lee HG; Kim JW; Lee K; Song EY
    Int J Mol Med; 2009 Dec; 24(6):765-71. PubMed ID: 19885616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
    Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
    World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.
    El-Abd N; Fawzy A; Elbaz T; Hamdy S
    Tumour Biol; 2016 Jan; 37(1):211-6. PubMed ID: 26189841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
    Zhang H; Yao M; Wu W; Qiu L; Sai W; Yang J; Zheng W; Huang J; Yao D
    Tumour Biol; 2015 Dec; 36(12):9373-83. PubMed ID: 26109000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
    Sun Y; Gao G; Cai J; Wang Y; Qu X; He L; Liu F; Zhang Y; Lin K; Ma S; Yang X; Qian X; Zhao X
    Carcinogenesis; 2013 Mar; 34(3):595-604. PubMed ID: 23188673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Annexin A2 as a novel diagnostic serum biomarker for lung cancer.
    Yang J; Yang F; Nie J; Zou X; Tian H; Qin Y; Liu C
    Cancer Biomark; 2015; 15(2):205-11. PubMed ID: 25519022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
    Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
    Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of Annexin A2 gene transcription down-regulation on human hepatoma cell biological behaviour].
    Zhang H; Yao M; Qian Q; Shi Y; Li J; Chen X; Wang S; Yao D
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):620-4. PubMed ID: 25243965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating annexin A2 as a biomarker in patients with pancreatic cancer.
    Karabulut M; Afsar CU; Serilmez M; Karabulut S
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S110-S115. PubMed ID: 33380663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
    Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
    Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.
    Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
    Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis.
    Liu Z; Ling Q; Wang J; Xie H; Xu X; Zheng S
    Oncol Lett; 2013 Jul; 6(1):125-129. PubMed ID: 23946789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
    Zhang A; Yin C; Wang Z; Zhang Y; Zhao Y; Li A; Sun H; Lin D; Li N
    J Int Med Res; 2016 Dec; 44(6):1414-1423. PubMed ID: 27885040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of anti-GP73 monoclonal antibodies and development of double-antibody sandwich ELISA.
    Li QW; Chen HB; Li ZY; Shen P; Qu LL; Gong LL; Xu HP; Pang L; Si J
    Asian Pac J Cancer Prev; 2015; 16(5):2043-9. PubMed ID: 25773808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin A2 as a differential diagnostic marker of hepatocellular tumors.
    Longerich T; Haller MT; Mogler C; Aulmann S; Lohmann V; Schirmacher P; Brand K
    Pathol Res Pract; 2011 Jan; 207(1):8-14. PubMed ID: 20971570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a sandwich ELISA method for detection of vascular endothelial growth factor in serum samples of hepatocellular carcinoma patients.
    Shan B; Gao C; Chen JM; Bi XY; Zhang BY; Guo Y; Dong CF; An R; Shi Q; Hu JQ; Zhao P; Han J; Dong XP
    Biomed Environ Sci; 2008 Feb; 21(1):69-74. PubMed ID: 18478981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures.
    Shi H; Xiao L; Duan W; He H; Ma L; Da M; Duan Y; Wang Q; Wu H; Song X; Hou Y
    Micron; 2016 Jun; 85():26-33. PubMed ID: 27060670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells.
    Zhang W; Zhao P; Xu XL; Cai L; Song ZS; Cao DY; Tao KS; Zhou WP; Chen ZN; Dou KF
    PLoS One; 2013; 8(8):e67268. PubMed ID: 23950866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.
    Bystricky B; Cierna Z; Sieberova G; Janega P; Karaba M; Minarik G; Benca J; Sedlackova T; Jurisova S; Gronesova P; Pindak D; Macuch J; Mardiak J; Mego M
    Anticancer Res; 2017 May; 37(5):2727-2734. PubMed ID: 28476852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.